chartexchange

Lipocine Announces Financial Results for the Third Quarter of 2026

PR Newswire | Nov 5, 2026 8:00 AM EST

SALT LAKE CITY, Nov. 5, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced financial results for the third quarter ended September 30, 2026 and provided a corporate update. Recent...

Read original article